Hengehold Capital Management’s West Pharmaceutical WST Stock Holding History

Hengehold Capital Management’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$242K	Buy	+674	New	+$206K	0.02%	208
2025 Q1	–	Sell	-679	Closed	-$222K	–	207
2024 Q4	$222K	Hold	679	–	–	0.02%	194
2024 Q3	$204K	Hold	679	–	–	0.02%	199
2024 Q2	$224K	Hold	679	–	–	0.02%	175
2024 Q1	$269K	Sell	679 -6	-0.9%	-$2.22K	0.03%	158
2023 Q4	$241K	Hold	685	–	–	0.03%	157
2023 Q3	$257K	Hold	685	–	–	0.03%	145
2023 Q2	$262K	Sell	685 -4	-0.6%	-$1.43K	0.03%	144
2023 Q1	$239K	Buy	+689	New	+$201K	0.03%	150
2022 Q3	–	Sell	-695	Closed	-$210K	–	162
2022 Q2	$210K	Hold	695	–	–	0.03%	146
2022 Q1	$285K	Hold	695	–	–	0.04%	132
2021 Q4	$326K	Sell	695 -8	-1%	-$3.44K	0.04%	128
2021 Q3	$298K	Hold	703	–	–	0.04%	129
2021 Q2	$252K	Buy	+703	New	+$232K	0.03%	135
2020 Q3	–	Sell	-884	Closed	-$201K	–	141
2020 Q2	$201K	Buy	+884	New	+$174K	0.04%	127

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Hengehold Capital Management's WST Position: Q2 2026 in Review

Hengehold Capital Management opened a new position in West Pharmaceutical (WST) in Q2 2026: 674 shares worth $242K. The stake represents 0.02% of the portfolio and ranks #208 among its holdings. This is a return to the name: Hengehold Capital Management previously reported a position in WST as recently as Q4 2024.

Hengehold Capital Management first reported a position in WST in Q2 2020 and has held it in 15 quarters since. The position peaked at $326K in Q4 2021. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

Hengehold Capital Management held 674 shares of West Pharmaceutical worth $242K as of Q2 2026.
West Pharmaceutical was a new Hengehold Capital Management position in Q2 2026.
West Pharmaceutical made up 0.02% of Hengehold Capital Management's portfolio in Q2 2026, its #208 holding.
Hengehold Capital Management first reported a position in West Pharmaceutical in Q2 2020 and has held it in 15 quarters since.
Hengehold Capital Management's West Pharmaceutical position peaked at $326K in Q4 2021.
834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Hengehold Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.